Cinacalcet administered early in the inactive phase markedly decrease parathyroid Ki-67 index. by Søren Egstrand (10906087)

“…<p>(A) Ki-67 expression in parathyroid glands of rats with CKD-induced sHPT treated with Cinacalcet either early in the inactive light phase (<i>Cina1</i>; N = 10) or early in the active dark phase (<i>Cina2</i>; N = 9) compared to untreated rats with sHPT investigated at similar time points (<i>PNX1</i>; N = 7 and <i>PNX2</i>; N = 7, respective) and to normal rats investigated at similar time points (<i>ctrl1</i>; N = 9 and <i>ctrl2</i>; N = 7, respective). …”

Conditional ablation of <i>Ybx1</i> leads to a reduction in cortical progenitor cell pool and a decrease in cortical thickness. by Jian Zhang (1682)

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

Subjects:

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

Subjects:

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

Subjects:

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

Subjects:

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

Subjects:

Overview of the WeARTolerance program. by Ana Beato (20489933)

Subjects:

GI-1d-a: Comparison of estimates of people for dataset A (left bar) and B (right bar) per region. The largest discrepancies occur in areas of NE, SE and SW Germany and adjacent reg... by Isabell Schmidt (6331013)

Subjects:

DataSheet1_Decreasing viscosity and increasing accessible load by replacing classical diluents with a hydrotrope in liquid–liquid extraction.docx by Asmae El Maangar (19690522)

“…We show that using hydrotropes as a diluent decreases the viscosity of solutions by more than a factor of ten, even under high load by extracted cations. …”

HSF2 regulates lytic gene expression in latency and during the lytic phase. by Lorenza Cutrone (21144285)

Subjects:

Primers used in ChIP-PCR. by Lorenza Cutrone (21144285)

Subjects:

Primers used in RTqPCR. by Lorenza Cutrone (21144285)

Subjects:

Image_1_Loss of CDYL Results in Suppression of CTNNB1 and Decreased Endometrial Receptivity.TIF by Xiaowei Zhou (1332225)

“…In addition, the expression of CTNNB1was decreased in the endometrium from RIF patients as well. …”

Table_1_Loss of CDYL Results in Suppression of CTNNB1 and Decreased Endometrial Receptivity.docx by Xiaowei Zhou (1332225)

“…In addition, the expression of CTNNB1was decreased in the endometrium from RIF patients as well. …”

Table_3_Loss of CDYL Results in Suppression of CTNNB1 and Decreased Endometrial Receptivity.docx by Xiaowei Zhou (1332225)

“…In addition, the expression of CTNNB1was decreased in the endometrium from RIF patients as well. …”

Image_4_Loss of CDYL Results in Suppression of CTNNB1 and Decreased Endometrial Receptivity.TIF by Xiaowei Zhou (1332225)

“…In addition, the expression of CTNNB1was decreased in the endometrium from RIF patients as well. …”

Image_3_Loss of CDYL Results in Suppression of CTNNB1 and Decreased Endometrial Receptivity.TIF by Xiaowei Zhou (1332225)

“…In addition, the expression of CTNNB1was decreased in the endometrium from RIF patients as well. …”

Image_8_Loss of CDYL Results in Suppression of CTNNB1 and Decreased Endometrial Receptivity.TIF by Xiaowei Zhou (1332225)

“…In addition, the expression of CTNNB1was decreased in the endometrium from RIF patients as well. …”

Image_2_Loss of CDYL Results in Suppression of CTNNB1 and Decreased Endometrial Receptivity.TIF by Xiaowei Zhou (1332225)

“…In addition, the expression of CTNNB1was decreased in the endometrium from RIF patients as well. …”